PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
04-Jun-2020 Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla® Lupin
04-Jun-2020 AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”) AMRYT PHARMA PLC
04-Jun-2020 Santhera Receives Financing Commitment of up to CHF 20 Million from Fund Managed by Highbridge Capital Management Santhera Pharmaceuticals
04-Jun-2020 Chi-Med Announces the Continuation of Phase III FRUTIGA Study of Fruquintinib in Second-Line Gastric Cancer in China Following a Planned Interim Data Review Chi-Med
04-Jun-2020 Smarter and faster FEP calculations enable more cost-efficient drug research Cresset
04-Jun-2020 Celltrion Healthcare showcases positive 1-year data and budget impact analysis for novel subcutaneous formulation of infliximab in patients with rheumatoid arthritis at the European E-Congress of Rheumatology 2020 Celltrion
04-Jun-2020 AlzeCure announces positive data from clinical study with ACD856 About AlzeCure® Pharma
04-Jun-2020 UNLOCKING THE POWER OF THE IMMUNE SYSTEM: UNCOVERING THE IMMUNOGENIC EFFECT OF CHEMOTHERAPY Cancer Research UK
04-Jun-2020 Stilla Technologies presents a novel approach for COVID-19 testing combining group testing with digital PCR and publishes the largest comparative study to date for group testing of SARS-CoV-2 Stilla Technologies
04-Jun-2020 ENHERTU® (Trastuzumab Deruxtecan) Achieved a Tumour Response Rate of 45.3% (95% CI, 70.2%-91.9%) in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial1 AstraZeneca
04-Jun-2020 NHS App Integrates eConsult for Online Consultations NHS
04-Jun-2020 VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy Astellas Pharma Inc
04-Jun-2020 AbbVie at EULAR | New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis AbbVie
04-Jun-2020 Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma Genmab A/S
03-Jun-2020 NOVO VENTURES LEADS US$55M SERIES B INVESTMENT IN NODTHERA Novo Holdings A/S
03-Jun-2020 COVID-19: Swedish company is awarded prestigious grant GAEU Consulting AB
03-Jun-2020 Sarclisa® (isatuximab) approved for the treatment of relapsed/refractory multiple myeloma in the EU1 Sanofi
03-Jun-2020 Helsinn Group announces FDA approval of a new liquid formulation of AKYNZEO® (fosnetupitant/palonosetron) injection in the United States Lugano
03-Jun-2020 The Holistic Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 The Holistic Report
03-Jun-2020 Orgenesis to collaborate with The Edith Wolfson Medical Center to conduct clinical study using Orgenesis’ proprietary POCare technologies for the generation and expansion of Tumor Infiltrating Lymphocytes Orgenesis Inc